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Abstract
Aims/Hypothesis: Duct cells isolated from adult human pancreas can be reprogrammed to express islet beta cell genes by
adenoviral transduction of the developmental transcription factor neurogenin3 (Ngn3). In this study we aimed to fully
characterize the extent of this reprogramming and intended to improve it.
Methods: The extent of the Ngn3-mediated duct-to-endocrine cell reprogramming was measured employing genome wide
mRNA profiling. By modulation of the Delta-Notch signaling or addition of pancreatic endocrine transcription factors Myt1,
MafA and Pdx1 we intended to improve the reprogramming.
Results: Ngn3 stimulates duct cells to express a focused set of genes that are characteristic for islet endocrine cells and/or
neural tissues. This neuro-endocrine shift however, is incomplete with less than 10% of full duct-to-endocrine
reprogramming achieved. Transduction of exogenous Ngn3 activates endogenous Ngn3 suggesting auto-activation of
this gene. Furthermore, pancreatic endocrine reprogramming of human duct cells can be moderately enhanced by
inhibition of Delta-Notch signaling as well as by co-expressing the transcription factor Myt1, but not MafA and Pdx1.
Conclusions/Interpretation: The results provide further insight into the plasticity of adult human duct cells and suggest
measurable routes to enhance Ngn3-mediated in vitro reprogramming protocols for regenerative beta cell therapy in
diabetes.
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Introduction
In the budding ducts of the embryonic pancreas, neurogenin3
(Ngn3) activation initiates the differentiation of epithelial progen-
itors to islet endocrine cells [1,2,3]. The presence of insulin-
producing cells in or close to the ductal epithelium of adult human
pancreas [4] has prompted the idea that islet endocrine cells in the
adult pancreas could bud off the ducts in the same way as they are
generated during embryogenesis. This process that is referred to as
beta cell neogenesis remains hypothetical in the human organ
since cell lineage tracing or specific protein markers for the newly
formed cells are lacking. Is the potential for endocrine repro-
gramming restricted to specific cell populations within the ducts?
Can this process be recapitulated in vitro and will it be possible to
improve its efficiency in vitro to yield clinically useful grafts for
beta cell transplantation? The answer to the latter questions was
partly given by previous finding that in vitro, human duct cells hold
the potential for partial endocrine reprogramming [5,6,7,8,9].
Previously, we demonstrated that ectopic expression of mouse
Ngn3 in cytokeratin 19 (CK19) positive human duct cell cultures
induced expression of several endocrine transcripts such as
synaptophysin (Syp), prohormone convertase 1/3, glucokinase
and insulin (Ins) [6].
The objectives of the present study were twofold. First, we
aimed to fully characterize the extent of Ngn3-mediated duct-to-
endocrine cell reprogramming, employing genome wide mRNA
profiling. Secondly, based on the newly gained knowledge we
intended to improve the reprogramming efficiency by enhancing
Ngn3-effects on adult human duct cells through (i) modulation of
Delta-Notch signaling [6,10] or (ii) addition of pancreatic
endocrine transcription factors myelin transcription factor 1
(Myt1) [11,12,13], MafA and Pdx1 [14]. We report that while
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a minor part of the estimated roadmap that needs to be followed to
fully convert exocrine duct to endocrine islet cells is achieved by
Ngn3 alone. In this model mouse Ngn3 interacts with the
promoter of human Ngn3 leading to its gene activation.
Enhancing this interaction by suppression of Delta-Notch signal-
ing is insufficient to further drive the reprogramming. While co-
expression of Ngn3 with MafA+Pdx1 also fails to drive the
reprogramming, the combination of Ngn3 and Myt1 is more
promising.
Results
Exogenous Ngn3 Activates Both Neuronal and Endocrine
Traits in Adult Human Duct Cells
Adult human duct cells were transduced with adenoviruses
expressing Ngn3 and GFP (AdGFP-Ngn3) or GFP only (AdGFP)
and cultured in suspension for 3 or 14 days to study their genome-
wide mRNA expression. Tables S1 and S2 list all transcripts that
were either 1.5-fold (LB) up- or down regulated in Ngn3-
transduced duct cells at day 3 (68 up, 36 down), day 14 (105 up,
19 down) or both. The Ngn3-associated transcriptome shift
consisted of 188 different genes that were altered at least at one
of the 2 time points tested (140 up and 48 down). Ngn3-activated
genes were however statistically (P,0.001) enriched in gene
ontologies relating to development, neurogenesis, synaptic trans-
mission, regulated hormone secretion and nuclear regulators.
Genes belonging to these overrepresented clusters are shown in
Table 1. Conventional and real-time PCR confirmed activation of
genes coding for beta cell transcription factors (NeuroD1, Pax4,
Nkx2.2), vesicle proteins (Scg3, Syp) insulin processing (Pcsk1) and
nutrient sensing (Gck), but also genes that are considered
characteristic for neural cells but are present in beta cells as well
(Pcp4, Rab26) (Figure S1).
The cell type-specificity of all genes that were activated by Ngn3
in human duct cells was further analyzed by integrating our
expression profiles of untransduced human duct and beta cells
with the Human Gene Atlas, containing more than 50 primary
human tissues and cell types [15]. Hierarchical clustering (Figure 1)
revealed that 6 25% of the Ngn3-activated genes in duct cells
show an endocrine cell-specific expression (Figure 1, cluster A), 6
25% are more characteristic for neural tissues (Figure 1, cluster B)
and another set of 6 20% transcripts appear similarly enriched in
neurons and endocrine cells (Figure 1, cluster C). A fully annotated
version of this heat map is provided as Figure S2. Combined, this
indicates that Ngn3 activates a shift towards a neuro-endocrine
phenotype.
Exogenous Ngn3 alone Cannot Fully Reprogram Adult
Human Pancreas Duct Cell Preparations into Islet
Endocrine Cells
We estimated the extent of duct-to-endocrine reprogramming
by two methods. First, in a genome-wide comparison, 1128
transcripts show 1.5-fold (LB, P,0.01) higher expression in
untransduced human islets versus duct cells. This gene set thus
needs to be activated for full conversion of a duct-to-endocrine
enriched cell fraction, and together it can be used to estimate the
required duct-to-beta reprogramming. Almost half of Ngn3-
activated genes (63 of 140, Figure 2A) belong to this gene set,
but overall Ngn3 fails to achieve full reprogramming with only 6%
(63 of 1128 transcripts) of the estimated path completed. Second,
Ngn3-activation focused on islet endocrine marker genes was
analyzed (Figure 2B), using a previously reported panel of 332
genes with conserved beta cell-abundant expression [16] : Ngn3
activated 24 such marker genes in duct cells, reaching on the
average 33% (range 6–104%) of the mRNA signal measured in
human beta cell fractions (Figure 2C–D). This confirmed that
reprogramming was incomplete, with 91% of conserved beta cell
marker genes not Ngn3-regulated. Both approaches thus indicate
that Ngn3 activates a restricted set of neural- and/or endocrine-
specific genes reflecting clear initiation but not completion of
pancreatic endocrine cell differentiation.
Exogenous Mouse Ngn3 Binds the Promoter of the
Endogenous Human Ngn3 gene and Provides Positive
Feedback
Microarray profiling revealed a 12-fold up-regulation of the
endogenous human neurogenin3 transcript (HsNgn3) in duct cells
14 days after transduction with cDNA encoding mouse neuro-
genin3 (MmNgn3) (Table 1). This is surprising since Ngn3 was
reported to control its own expression through negative feedback
during mouse embryonic development [17]. Because the vector-
derived sequence is limited to the open reading frame of MmNgn3
and 11 out of the 12 HsNgn3-specific microarray probes are
specific for the 39 untranslated Ngn3 region, this represents
genuine activation of endogenous HsNgn3. Increased expression
of HsNgn3 was confirmed by RT-PCR primers that specifically
amplify transcripts of either HA-tagged exogenous MmNgn3
cDNA or endogenous HsNgn3 (Figure 3A): the HsNgn3 transcript
became detectable 2 days after AdGFP-Ngn3 transduction,
peaking at 7 days and then decreased to reach the lower detection
limit 3 weeks after transduction. Chromatin immunoprecipitation
revealed an in vivo binding of HA-tagged MmNgn3 protein to the
59 region of the HsNgn3 gene but not to negative control genomic
fragments of the CTLA-1 and BRCA1 genes (Figure 3B). These
studies therefore provide for the first time evidence for endogenous
autoactivation of Ngn3.
Delta-Notch Signaling Antagonizes Ngn3-induced
HsNGN3 Activation and Neuro-endocrine Differentiation
Ngn3 is insufficient for a full reprogramming of duct cells to a
genuine endocrine phenotype. Delta-Notch signaling is candidate
for permissive instruction of the Ngn3-transduced cells and
therefore its role in the reprogramming process was investigated.
Exogenous Ngn3 provoked a coordinated activation of genes
coding for Delta-Notch signaling proteins, like Dll1, Dll4 [6] and
Lnf (Table S1) that could limit reprogramming efficiency.
Therefore, the impact of Notch signal inhibition was investigated
by loss- and gain-of-function experiments. Addition of the gamma-
secretase inhibitor L685,458 (L6) prevents the proteolytic forma-
tion of the bioactive intracellular Notch domain (NICD). L6
increased the activation of endogenous HsNgn3 in AdGFP-Ngn3
but had no effect in control transduced duct cells (Figure 4A,B).
This accentuation of HsNgn3 expression, however, caused only a
tendency towards increased insulin and synaptophysin mRNA
levels (Figure 4A). Vice versa, when constitutively active NICD
was ectopically expressed in adult human duct cells together with
Ngn3, activation of endogenous HsNgn3 was blunted, leading to
lower insulin and synaptophysin transcript levels (Figure 4A).
Thus, active Notch signaling suppresses Ngn3 autoactivation in
adult pancreatic duct cells.
Myt1 Enhances Ngn3-induced Reprogramming
Myelin transcription factor 1 (Myt1) is another important islet
cell transcription factor and works in concert with Ngn3 to
promote endocrine cell differentiation in the developing pancreas
[11,12,13]. Myt1-encoding mRNA was absent from normal duct
Ngn3-Mediated Duct-to-Beta Cell Reprogramming
PLoS ONE | www.plosone.org 2 May 2012 | Volume 7 | Issue 5 | e37055Table 1: Selection of Ngn3-activated genes in suspension cultured human duct cells.
Gene Symbol Accession Gene name Fold Ngn3/Ctrl
Fold
Ngn3 endocrine Cluster
D3 D14 D14/D3 abundance Fig. 2
Development - Neurogenesis
ISL1 NM_002202 ISL1 transcription factor, LIM/homeodomain, (islet-1) 1,2 2,4 * 2,4 * 26,9 A
INSM1 NM_002196 insulinoma-associated 1 64,7 * 82,4 * 3,3 * 25,3 A
NKX2-2 NM_002509 NK2 transcription factor related, locus 2 (Drosophila) 5,4 * 23,3 * 6,3 * 19,9 A
Ascl1 BC001638 achaete-scute complex-like 1 (Drosophila) 1,1 48,9 * 54,9 * 4,4 A
BACE1 NM_012104 beta-site APP-cleaving enzyme 1 1,2 1,9 * 1,5 2 A
NEUROD1 NM_002500 neurogenic differentiation 1 4,2 * 30,9 * 12,5 * 21 B
NLGN1 NM_014932 neuroligin 1 21,5 1 2,1 * 1,4 B
SIM1 AL121948 single-minded homolog 1 (Drosophila) 1,2 1,4 2 * 1,2 B
PAX4 AB008913 paired box gene 4 1,5 2,4 * 2 * 1 B
OLFML2B AW007573 olfactomedin-like 2B 3,6 * 2 21,5 0,7 B
NEUROG3 NM_020999 neurogenin 3 1,7 12,5 * 5,9 * 0,7 B
NHLH1 M96739 nescient helix loop helix 1 1,2 2,3 * 1,9 0,6 B
NEUROG1 NM_006161 neurogenin 1 2,7 * 1,1 22,2 0,5 B
NHLH2 AA166895 nescient helix loop helix 2 1,6 4,3 * 3 * 0,5 B
STMN2 BF967657 stathmin-like 2 1,5 5,5 * 7,4 * 10,8 C
PCP4 NM_006198 Purkinje cell protein 4 2,1 4,7 * 3,4 * 5,9 C
APLP1 U48437 amyloid beta (A4) precursor-like protein 1 1,6 3,5 5,8 * 5,8 C
TM4SF2 NM_004615 tetraspanin 7/transmembrane 4 superfamily member 2 1,3 2,5 * 2,7 * 5 C
SERPINI1 NM_005025 serine (or cysteine) proteinase inhibitor, clade I, member 1 2 2,6 * 21,2 2,1 C
AF1Q BC006471 ALL1-fused gene from chromosome 1 q 1 1,4 1,9 * 1,2 C
NPTX1 NM_002522 neuronal pentraxin I 45,3 * 64,1 1,3 0,9 C
MT3 NM_005954 metallothionein 3 (growth inhibitory factor (neurotrophic)) 2,1 * 1,2 21,6 0,6 C
S100A1 NM_006271 S100 calcium binding protein A 1 5,4 * 9,2 * 2 0,5 C
PAX6 AW088232 paired box gene 6 (aniridia, keratitis) 1,2 5,3 * 5,2 * 22
FOXA2 AL121722 hepatocyte nuclear factor 3, beta 2,4 * 2,6 * 21,3 22
PHC2 AA431100 polyhomeotic-like 2 (Drosophila) 21,2 1,2 2 * 22
GDAP1 BF002104 ganglioside-induced differentiation-associated protein 1 1,2 2,9 * 2 22
Neuroendocrine - Synaptic Function
SGNE1 NM_003020 secretory granule, neuroendocrine protein 1 (7B2 protein) 1,1 2,8 * 2,9 * 62,5 A
SCG3 NM_013243 secretogranin III 3,9 7,5 * 5,1 * 55,6 A
SCG2 NM_003469 secretogranin II (chromogranin C) 1,3 6,9 * 6,5 * 31,1 A
CPE NM_001873 carboxypeptidase E 1,7 3 * 2,2 * 29,2 A
SST NM_001048 somatostatin 21,1 2,5 5,8 * 28,4 A
CHGB NM_001819 chromogranin B (secretogranin 1) 1,5 2,7 * 3,1 * 27 A
PCSK1 NM_000439 proprotein convertase subtilisin/kexin type 1 1,4 19,7 * 15,9 * 17,3 A
PCSK2 NM_002594 proprotein convertase subtilisin/kexin type 2 1,8 2,4 3,3 * 15,4 A
CHGA NM_001275 chromogranin A (parathyroid secretory protein 1) 1,4 10,4 * 12,2 * 14,2 A
ENPP2 L35594 ectonucleotide pyrophosphatase/phosphodiesterase 2 1,6 5,3 * 3,8 * 13 A
SCGN NM_006998 secretagogin, EF -hand calcium binding protein 3,2 23,8 * 7,6 * 9,8 A
KCNH2 NM_000238 potassium voltage-gated channel, subfamily H, member 2 21 2,4 * 2,2 4 A
CADPS NM_003716 Ca2+-dependent secretion activator 1,4 2,4 * 1,5 6,2 B
NBEA NM_015678 neurobeachin 1,1 2,1 * 1,7 1,4 B
RAB26 NM_014353 RAB26, member RAS oncogene family 3,6 * 8,4 * 2,6 1 B
RTN2 NM_005619 reticulon 2 7,9 * 13,4 21,8 0,7 B
HPCA BC001777 hippocalcin 8,1 8,8 * 7,2 * 0,6 B
SNAP25 NM_003081 synaptosomal-associated protein, 25 kDa 21 1,7 3,3 * 14,3 C
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we over-expressed Myt1b, the Myt1 isoform that is predominantly
active in embryonic chicken and mouse pancreas [11,12], to
investigate whether more Myt1, alone or in combination with
Ngn3 could enhance duct-to-endocrine cell reprogramming. After
10 days, Myt1b alone enhanced transcript levels of the insulin and
glucagon genes to a minor extent and of the synaptophysin gene to
a major extent. Only the latter one and glucokinase were increased
in duct cells transduced by Ngn3 only (Figure 5A). Introduction of
Myt1b in Ngn3-expressing duct cells further increased transcript
levels of synaptophysin and glucokinase (P,0.05) but not of insulin
and glucagon (Figure 5A). However, no significant increase in
protein levels of insulin and synaptophysin could be detected. The
Ngn3-induced neuro-endocrine shift occurs through recapitulation
of embryonic neuro-endocrine differentiation [6], i.e. by activation
of its direct target genes [6,18,19,20,21]. The abundance of
transcripts coding for NeuroD1, Pax4 and Insm1 increased in duct
cells transduced with Ngn3 but not Myt1 only. Myt1b further
enhanced the amount of Ngn3-induced Pax4 mRNA (4-fold,
P,0.001) (Figure 5B). The lack of additive effects of Myt1b on
most direct targets of Ngn3 suggests that Myt1b and Ngn3 can act
through parallel pathways.
No Effect of Combined Pdx1 and MafA on Ngn3-induced
Reprogramming
Adenoviral expression of Ngn3, Pdx1 and MafA has been
reported to reprogram mouse pancreatic acinar cells in vivo into
insulin-expressing cells [14]. The reprogramming potential of
human duct cells either by Ngn3 alone or by combination with
Pdx1 and MafA, were directly compared taking insulin and
synaptophysin mRNA levels as readout. Addition of MafA and
Pdx1didnotsignificantlyenhanceNgn3-inducedinsulin(Figure5C)
or synaptophysin (Figure 5D) mRNA levels in duct cells.
Table 1. Cont.
Gene Symbol Accession Gene name Fold Ngn3/Ctrl
Fold
Ngn3 endocrine Cluster
D3 D14 D14/D3 abundance Fig. 2
SCN1B NM_001037 sodium channel, voltage-gated, type I, beta 1,5 2,5 * 1,9 * 2,4 C
SV2A NM_014849 synaptic vesicle glycoprotein 2A 1,1 1,9 2,4 * 1,6 C
SYT11 AA626780 synaptotagmin XI 1,1 1,6 2,1 * 1,6 C
SYP U93305 synaptophysin 1,1 3,6 * 2,8 * 1,4 C
RPIP8 AI197870 RaP 2 interacting protein 8 21 1,5 1,8 * 1,2 C
SYNGR3 NM_004209 synaptogyrin 3 21,4 1,1 1,9 * 1,2 C
CAMK2B AF078803 calcium/calmodulin-dependent protein kinase II beta 1,2 2,4 * 2,1 * 1,1 C
KCNF1 AF029780 potassium voltage-gated channel, subfamily F, member 1 6,1 6,4 * 1,2 0,8 C
CABP7 AI989906 calcium binding protein 7 4,1 * 18,1 * 3,1 * 22
CPLX1 BC002471 complexin 1 3,7 * 3,5 * 1,1 22
CPNE5 AB046819 copine V 23,2 21,3 2,6 * 22
SYT4 AB037763 synaptotagmin IV 1 2,8 * 2,2 * 22
SYT13 AB037848 synaptotagmin XIII 1,1 2,1 * 1,7 22
Nuclear - Transcription
ST18 NM_014682 suppression of tumorigenicity 18 (breast carcinoma) 1,4 7,9 * 4,9 * 11,4 A
ETV1 BE881590 ets variant gene 1 21,5 1,6 2,2 * 9,6 A
BTBD3 NM_014962 BTB (POZ) domain containing 3 1 2 * 2 * 7,5 A
BEX1 NM_018476 brain expressed, X-linked 1 21,2 1,6 2,2 * 7,4 A
NALP1 NM_021730 NACHT, leucine rich repeat and P Y D containing 1 1,1 10,3 * 9,9 * 7 A
CUL3 NM_003590 cullin 3 1 7,3 * 6,9 * 3,6 A
ZNF505 AC007204 zinc finger protein 505 2,9 * 1,4 21,8 1,1 B
HMGB3 NM_005342 high-mobility group box 3 1,5 2,1 * 1,4 0,9 B
FEV NM_017521 FEV (ETS oncogene family) 21 9,3 * 12,7 * 0,8 B
LOC51337 NM_016647 mesenchymal stem cell protein DSCD75 1,1 2,1 * 1,8 0,7 B
BPY2 NM_004678 basic charge, Y-linked, 2 4 * 1,8 22,2 0,5 B
SOX2 AI669815 SRY (sex determining region Y )-box 2 2,3 15 * 10,4 * 22
HIC2 AK024950 Hypermethylated in cancer 2 21,1 1,5 3,8 * 22
140 transcripts on HG133A array transcripts are at least 1.5-fold (LB) activated by AdGFP-Ngn3 in human duct cells. Ngn3-activated genes are statistically enriched
(P,0.001) in gene ontologies of development, neurogenesis, synaptic transmission, regulated hormone secretion and nuclear regulators; genes belonging to these
clusters are shown. From left to right, columns indicate fold transcript accumulation in AdGFP-Ngn3 versus AdGFP control cells at 3 (D3) or 14 (D14) days post
transduction. Two columns on the right refer to the analysis of tissue tropism in Figure 1: endocrine cell abundance indicates relative mRNA abundance in human
endocrine cells as compared to the other tissues profiled in Figure 1. Last column indicates in which cluster (A, B, C) of Figure 1 the gene is situated.
*P,0.05, n=3.
doi:10.1371/journal.pone.0037055.t001
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The potential of reprogramming duct-to-beta cells to replenish
the endocrine cell pool in diabetes patients remains controversial.
Since no reliable in situ protein markers for human islet neogenesis
are available the presence of small beta cell aggregates or single
insulin expressing cells close to or in the pancreatic ducts are
typically used as surrogate markers [4,22]. Several reports
described the production of endocrine material from islet-depleted
leftover fractions from human pancreas after beta cell isolation
[5,8,23,24]. However, the efficiency of these processes is low and
the newly formed endocrine cells show an inadequate response to
glucose. Moreover, reports based on genetic-lineage tracing of
duct cells in different mouse models of beta cell regeneration are
inconclusive [25,26,27]. Transgenic mice in which the promoter of
human carbonic anhydrase II (CAII), a ductal marker, drives the
expression of (inducible) Cre recombinase showed that CAII-
expressing cells can act as progenitors giving rise to new islets and
acini after birth and in adult mice after partial duct ligation [25].
In contrast, when Hepatocyte nuclear factor 1b (Hnf1b), another
marker of mature duct cells, was driving inducible reporter
expression, fully mature duct cells did not contribute to new islet
cells after partial duct ligation [27].
The fundamental question remains whether non-endocrine cells
in the adult human pancreas retain a regenerative potential and
whether this potential can be revealed and exploited in vitro using
transcriptional regulators of beta cell differentiation, like Ngn3.
Our prior work showed that, at least in vitro, human duct cells can
be partly reprogrammed towards a neuro-endocrine, beta cell-like
phenotype: ectopic overexpression of mouse Ngn3 activated the
expression of several endocrine-specific genes, such as synapto-
physin, prohormone convertase 1, glucokinase, chromogranin A
[6].
A first objective of the present study was to quantify the extent
of this Ngn3-mediated duct-to-endocrine cell reprogramming
using genome-wide mRNA profiling. This confirmed the activa-
tion of key endocrine cell genes as previously reported [6], but at
the same time provides a more realistic estimation of the overall
duct-to-endocrine cell reprogramming: it turned out to be
Figure 1. Ngn3 induces endocrine cell-enriched and neural-enriched genes in ducts. We analyzed all transcripts that are Ngn3-activated in
suspension cultured duct cells (n=140 on HG133A) in a public dataset of more than 50 human tissues and cell types (each n=2), supplemented by
our endocrine cell hybridizations (n=3). The cluster graph thus shows the relative tissue-selectivity of the Ngn3-induced transcripts. Approximately
25% of Ngn3-regulated transcripts are selectively enriched in endocrine cells/pancreatic islets (cluster A). Cluster B genes are enriched in the central
nervous system but generally not in pancreatic endocrine cells. Cluster C exhibit a neuro-endocrine expression pattern, with comparable expression
in central nervous system and endocrine cells. An annotated version of Figure 1 with full gene names is included as Figure S2.
doi:10.1371/journal.pone.0037055.g001
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primary duct to endocrine cells reached. This shift, estimated by
batch analysis of the whole duct cell preparation, can underesti-
mate the reprogramming that individual Ngn3-expressing duct
cells achieve, since only 30 to 40% of cells in suspension culture
were transduced, as judged by GFP expression. Moreover, it is
uncertain if all transduced cells necessarily have the same
reprogramming susceptibility. Although the overall transcriptome
of Ngn3-transduced duct cells differed markedly from that of a
typical islet endocrine cell, the phenotypic shift was highly
enriched in gene clusters that are characteristic for islet endocrine
cells. It also contained many genes that are more characteristic for
neural tissues or with a shared abundance in islet endocrine and
neural cells. It is well known that despite their different embryonic
origin, endocrine islet cells and neuronal cells share similarities in
their gene activity profile [28], more specifically Ngn3 expression
during the development [29,30,31,32,33]. Our findings therefore
suggest that the transduction of adult duct cells by Ngn3 can
induce neural genes that are not normally activated in adult
endocrine cells, reflecting differences between embryonic progen-
itor cells and the adult cells employed in the current study.
Our study on primary human cells allows a comparison of
candidate Ngn3 target genes identified in earlier mouse cell line
studies. A previous report [34] described 51 differentially regulated
genes in the mouse pancreatic duct tumor cell line mPAC, 48 h
after ectopic expression of mouse Ngn3. Only 8 of these 51 (16%)
were also Ngn3-regulated in adult human duct cells: in both
models Ngn3 activated endogenous Ngn3, Nkx2.2, Pax6,
NeuroD1, Hes6, Isl1, somatostatin and glucokinase but not
Nkx6.1 and Glut2. Despite this limited overlap, the general tissue
tropism or functional ontologies of Ngn3 target genes in both
Figure 2. Extent of Ngn3-mediated duct-to-islet endocrine reprogramming. Transcripts that are $1.5-fold (LB) higher expressed in
untransduced human endocrine versus suspension cultured duct cells (n=1128 on the HG133A array, panel A, green) were compared to the 140
transcripts that were AdGFP-Ngn3-activated as compared to AdGFP-transduced duct cells using the same statistical criteria (panel A and B, gray).
Nearly half (45%, 63 of 140) of Ngn3-regulated transcripts (panel A, intersect) are expressed in endocrine cells. Panel B compares these 140 Ngn3-
activated transcripts (gray) to a previously reported [16] panel of 332 genes with beta cell-selective expression in mouse, rat and human. Ngn3
activated 24 of these endocrine marker genes. Gene chip mRNA expression signal (mean6SD, n=3) in transduced duct cells is shown in panels C and
D.
doi:10.1371/journal.pone.0037055.g002
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neurogenesis and Notch signaling.
Mouse Ngn3 switched on the endogenous human NGN3 gene.
This was surprising since Ngn3 was shown by others to inhibit its
own expression during embryonic mouse development [10,17].
This peculiar feature involved an interaction of mouse Ngn3 with
the 59 region of the human NGN3 that is at least partially
modulated by Delta-Notch signaling.
A second objective was to improve reprogramming efficiency by
Ngn3. We therefore first targeted the Delta-Notch pathway: since
lateral inhibition by active Notch is likely to constrain endocrine
specification, we suppressed it pharmacologically by gamma-
secretase inhibitor. Notch suppression further accentuated the
observed feed-forward stimulation of mouse on human Ngn3, but
did not significantly drive endocrine reprogramming taking insulin
and synaptophysin mRNA levels as markers.
In an alternative attempt to improve reprogramming, we tried
to mimic combinations of transcription factors that are active in a
timed cascade during in vivo endocrine differentiation. Ectopic
expression of Myt1b in the developing chicken gut endoderm [11]
and in mouse pancreatic progenitor cells [13] results in an
increased number of glucagon-positive cells. Similar observations
were reported when Ngn3 was ectopically expressed in embryonic
endoderm from chicken [35] and mouse [31,36]. A close inter-
dependence of both factors is likely since Myt1-induced endocrine
differentiation is blunted in embryos of Ngn3 null mice [12]. In
adult human duct cells, Myt1 alone was sufficient to increase
mRNA levels of insulin, glucagon and synaptophysin. Myt1 had
Figure 3. Ngn3 induces its own expression via direct binding on its own promoter. (A) RT-PCR detection of exogenous and endogenous
Ngn3 in AdGFP-Ngn3 transduced duct cells. Time course detection of exogenous HA-Ngn3 and endogenous Ngn3 mRNA showing sustained
endogenous Ngn3 expression. Time points are indicated in hours (8–64) or days (1–21). Open triangle: genomic Ngn3 PCR fragment; black triangle:
endogenous Ngn3 cDNA PCR fragment. Gapdh-specific RT-PCR is included as template control (n=3). (B) Chromatin immunoprecipitation with an
anti-HA antibody on chromatin derived from adult human duct cells transduced with either AdGFP-Ngn3 or AdGFP. DNA from input chromatin was
serially diluted as a reference for semiquantitative PCR analysis. In the AdGFP-Ngn3 samples both NGN3 and NEUROD1 promoter fragments are
enriched with antibodies directed against the HA tag, suggesting that Ngn3 binds both endogenous wild type promoters. NGN3 and NEUROD1
promoter fragments were not detected in AdGFP control samples, neither were the negative control genomic fragments from the CTLA-1 and BRCA1
genes (n=2).
doi:10.1371/journal.pone.0037055.g003
Figure 4. Modulation of Delta-Notch signaling affects Ngn3 induced endocrine differentiation in adult human duct cells. (A) Real
time PCR quantification of endogenous Ngn3, Ins and Syp in AdGFP-Ngn3 transduced duct samples (white bars) versus gamma-secretase inhibitor
L6-treated samples (gray bars), shows increased expression levels of endogenous NGN3 (*P,0.05) and the endocrine marker genes (NS, n=3).
Expression of Ngn3, Ins and Syp is reduced when AdGFP-Ngn3 cells are additionally transduced with the Notch1 intracellular domain (NICD) (black
bars). Data represent mean 6 SEM real-time PCR measurements of target/Ppia mRNA levels compared to AdGFP-Ngn3 transduced duct cells. (B)
Conventional PCR showing an increased activation of endogenous HsNgn3 in AdGFP-Ngn3 adult human duct cells treated with L6, but no effect in
control transduced duct cells. Controls of exogenous expression (HA-Ngn3 and GFP) as well as expression levels of housekeeping gene GAPDH are
shown.
doi:10.1371/journal.pone.0037055.g004
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Ngn3 targets such as NeuroD1, Nkx2.2, and Insm1 whereas it
enhanced transcription of Pax4. Myt1 thus exerts its (neuro-)
endocrinogenic effects mainly independently from Ngn3 under the
present experimental conditions. However, Myt1- and Ngn3-
induced downstream programs seem to converge at some point
since duct cells co-expressing both factors systematically showed
the highest levels of synaptophysin, glucokinase and Pax4
transcripts.
The combination of MafA, Pdx1 and Ngn3 has recently been
reported to drive the reprogramming of acinar to endocrine cells
in the pancreas of adolescent immune-compromised mice [14]. In
adult human duct cells, however, this transcription factor cocktail
was not efficient as compared to Ngn3 alone. Several non-
exclusive explanations are possible: perhaps differentiated acinar
cells are required for proper reprogramming, potential species- or
age-related factors are overlooked [37], or in the in vitro model
does not support survival of crucial cell subpopulations or lacks
inductive signals normally active in vivo.
These considerations are also pertinent with regard to the
limited overall efficiency of Ngn3-induced reprogramming, and
the limited added benefit of Notch suppression or Myt1 co-
expression. In the developing pancreas, Ngn3 drives endocrine
development in a complex cascade that is finely timed [1,31] and
likely topographically regulated by signals form the mesenchyme
surrounding progenitor niches. None of these criteria are fulfilled
in the cultured adult pancreatic duct cell preparations, with their
sustained high-level expression of Ngn3. Another limitation of our
model is its sole intervention at the transcriptional level with no
control of epigenetic constraints. Both exocrine and endocrine
cells arise from the same pancreatic progenitor and as this
progenitor differentiates towards an exocrine fate, several genes
important for endocrine differentiation are repressed at the
epigenetic level. More work is needed to map the differences in
epigenetic traits of pancreatic cell types and determine if reversal
Figure 5. Overexpression of pancreatic endocrine transcription factors in adult human duct cells. (A, B) Effect of Myt1b overexpression
in adult human duct cells. Adult human duct cells have been transduced with AdGFP, AdGFP-Ngn3 and/or AdGFP-Myt1 with a total MOI 100 and
gene expression profiles have been analyzed 10 dpt. (A) Increased levels of several neuroendocrine genes are observed in AdGFP-Myt1 duct cells. The
effects are enhanced by overexpression of Myt1 and Ngn3. (B) Except for Pax4, Myt1 does not upregulate known Ngn3 target genes. P,0.05 vs
AdGFP (*) or AdGFP-Myt1 (#); P,0.005 vs AdGFP (**) or AdGFP-Myt1 (##); P,0.001 vs AdGFP (***) or AdGFP-Myt1 (###). (C, D) Adenoviral
overexpression of Pdx1, Ngn3 and MafA in adult human duct cells does not induce the neuroendocrine genes Ins and Syp. Adult human duct cells
have been transduced with control viruses AdGFP and AdNull, AdGFP-Ngn3+AdGFP+AdNull or AdGFP-Pdx1+AdGFP-Ngn3+AdMafA with a total MOI
of 100 and gene expression has been analyzed 10 dpt. RT-qPCR analysis reveals that none of these conditions induced insulin or synaptophysin
transcripts. Data represent mean 6 SEM real-time PCR measurements of target/Ppia mRNA levels compared to non-transduced adult human duct
cells (n $3).
doi:10.1371/journal.pone.0037055.g005
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ming.
In summary, ectopic expression of Ngn3 in adult human duct
cells produces a focused shift of gene expression with activation of
many neuron- and/or islet endocrine genes. This shift is
moderately enhanced by suppression of Notch, and by co-
expression of Myt1 but not MafA plus Pdx1. Though our study
confirms an intriguing level of plasticity of the adult human duct
cells, the overall reprogramming based on currently available
protocols is limited and more is needed for differentiation to
clinically useful beta cell grafts.
Materials and Methods
Ethics Statement
Ethical approval to use endocrine- and exocrine-enriched cells
derived from donor organ was given by the Medical ethical
committee of the University Hospital of the Vrije Universiteit
Brussel (O.G. 016) to the Beta Cell Bank-University Hospital
Brussels (permission 2010/193). Permission was also given to Dr.
Heimberg by the Ethical Committee to use these cells for in vitro
studies aimed to develop improved transplantation conditions
(2008/048).
Production of Recombinant Adenoviruses
Coding sequences of hemagglutinin (HA)-tagged mouse Ngn3,
myc-tagged mouse Myt1b and mouse Pdx1 were subcloned in
pAdTrack-CMV and constitutively expressed under the control of
the CMV promoter. pAdTrack-CMV contained the enhanced
green fluorescent protein (eGFP) cDNA downstream of a second
CMV promoter. Recombinant, replication-deficient adenoviruses
expressing GFP (AdGFP), Ngn3 in combination with GFP
(AdGFP-Ngn3), Myt1 in combination with GFP (AdGFP-Myt1)
and Pdx1 in combination with GFP (AdGFP-Pdx1) were
generated following the standard protocol as described [38]. The
recombinant adenovirus coding for MafA (AdMafA) was obtained
through the Beta Cell Biology Consortium. Since this virus did not
encode a reporter gene, ‘‘AdNull’’, consisting of the adenoviral
backbone lacking any transgene, was used as control.
Cell isolations, Cell Culture and Viral Transduction
Human cells were obtained from heart-beating cadaveric
nondiabetic donors. Full written consent was given by the family
to use the donor organ for research purposes according to the
Belgian laws. Ethical approval to use endocrine- and exocrine-
enriched cells derived from donor organ was given by the Medical
ethical committee of the University Hospital of the Vrije
Universiteit Brussel. In the non-endocrine fraction, ,5%
expressed the islet cell marker Syp+ and .90% expressed the
duct cell-specific marker CK19+ [6,39] when cultured at least 4
days [40]. The non-endocrine cell preparation was cultured in
suspension in Ham’s F10 (Bio-Whittaker, Fontenay-sous-bois,
France), 0,5% BSA (Boehringer Mannheim; Indianapolis, IN),
7.5 mM glucose, 100 U/ml penicillin, 100 mg/ml streptomycin
and 1 mM L-glutamine at 37uC in a humidified atmosphere. On
day 4 of culture, cells were counted, transduced and further
cultured in suspension at a cell density of 70 K cells/cm
2.
Alternatively, day 4 cells were counted and plated to form
monolayers on tissue-culture plastic multiwells with a cell density
of 70 K cells/cm
2. Monolayer cells were cultured in the same
medium as suspension with the addition of 5% FBS (Life
Technologies, Carlsbad, CA, USA) and transduced 6 days later.
Unless stated otherwise, the cells were maintained in monolayer
culture. Transduction was performed under serum-free conditions
during 4 hours at multiplicity of infection (MOI) of 50, unless
stated otherwise. Under all conditions, cell culture medium was
renewed every other day. The endocrine-enriched fraction
consisted of 5566% insulin+ cells, 1264% glucagon+ cells and
2264% non-granulated cells. The gamma secretase inhibitor
L685,458 (L6) was purchased from Calbiochem (Merck, Darm-
stadt, Germany) and used at a final concentration of 100 nM.
Genome-wide mRNA Expression Profiling
Quality of TRIzol (Gibco BRL, Carlsbad, CA, USA) extracted
RNA was verified on a 2100 Bioanalyzer (Agilent, Waldbronn,
Germany), taking minimal cutoff RIN $ 8. The microarray
analysis was performed on 3 independent samples that each
contained RNA extracted from a pool of 3 independent donor
pancreata. The total number of non-selected donor organs is 9.
Each RNA sample contained equal amounts of RNA extracted
from the individual donor organs. A total of 5 mg of RNA was used
to synthesize double-stranded cDNA with the Superscript Choice
system (Invitrogen, Merelbeke, Belgium) using an oligo(dT) primer
containing a T7 RNA polymerase promoter (GenSet, Paris,
France). The cDNA was used as the template for an in vitro
transcription reaction to synthesize biotin-labelled antisense cRNA
using the BioArray high yield RNA transcript labelling kit (Enzo
Diagnostics, Farmingdale, New York, USA). After fragmentation
at 94uC for 35 min in fragmentation buffer (40 mM Tris, 30 mM
magnesium acetate, 10 mM potassium acetate), the labelled cRNA
was hybridized for 1 6 h to the Affymetrix HG133A and/or
HG133B chip analyzing over 45,000 probe sets, probing
expression of 39,000 transcripts corresponding to 33,000 anno-
tated human genes (Affymetrix Inc., Santa Clara, CA, USA).
Arrays were stained with phycoerythrin-streptavidin with the
Affymetrix Fluidics Station 400, and scanned in the Affymetrix
GeneArray2500scanner. Scanned arrays were analyzed with
dChip model-based expression analysis to the array with the
median intensity (AdGFP duct 3 days post transduction, intensi-
ty=180); mean6SD intensity for the whole group was 181639,
ranging from 111 to 262 with no statistical outlying arrays [41].
Using the PM-MM model with mismatch correction, a 90%
confidence interval was calculated for the fold change in gene
expression in each comparison, and the lower limit of this interval
(LCB) was used as a measure of differential gene expression.
Transcripts were considered as differentially regulated by Ngn3
when 1.5 fold (LCB, unpaired P,0.05) up- or down-regulated in
AdGFP-Ngn3 versus AdGFP controls, at 3 and/or 14 dpt.
Transcripts that showed differential expression between day 3
and day 14 in AdGFP-Ngn3 duct cells but not in AdGFP control
cells, were also considered Ngn3-regulated. dChip was also used
for analysis of statistical over-representation of Gene Ontologies in
the set of Ngn3-activated genes, taking P,0.001 as threshold for
significant enrichment.
Raw data are publicly available at Gene Expression Omnibus as
GSE30802 (AdGFP or AdGFP-Ngn3 transduced duct cells) and
GSE30803 (untransduced human beta and duct cell preparations,
and other human tissues).
Analysis of Ngn3-induced phenotypic shift by tissue-
comparative mRNA expression profiling
Abundances of AdGFP-Ngn3-regulated transcripts were visual-
ized in the Human Genome Atlas data set [15], supplemented
with our human duct and endocrine cells. After normalization to
array with median intensity and modeling using mismatch
correction, dChip was used to obtain a view of the global
phenotypic shift by hierarchical clustering (correlation, centroid)
and gene ontology clustering for statistically overrepresented
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webtool [42].
RNA Analysis
Total RNA was isolated using the RNeasy Minikit (Qiagen,
Hilden, Germany). 250 ng RNA was reverse transcribed with
SuperScript II Reverse Transcriptase and random hexamers
according to the manufacturer’s instructions and conventional
PCR was performed using Taq DNA polymerase (Invitrogen,
Paisley, UK). For primer sequences, see Table S3A. Alternatively,
quantitative RT-PCR was performed using TaqMan Fast
Universal PCR Master Mix and TaqMan Assays (Table S3B)
(Applied Biosystems, Foster City, CA, USA). As no cDNA specific
assays were available for human Ngn3 (hsNgn3) nor HA-tagged
mouse Ngn3 (mmNgn3), corresponding primers and probes were
designed (59–39): hsNgn3 forward TTGCGCCGGTAGAAAG-
GATG, reverse GCGGACGTGGGGCAGGTC, probe CCCA-
GAGCCTCGGAAGACGAA; mmNgn3: forward GCTACCCA-
TACGATGTTCCA, reverse GGAGCAGTCCCTAGGTATG,
probe CCGGAGCCTCGGACCACGAA.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation experiments were performed
as described [21]. Immunoprecipitation was performed with 5 mg
mouse anti-HA (Roche) overnight at 4uC, followed by 4 h
incubation at 4uC with 3 mg rabbit anti-mouse IgG (Sigma). For
primer sequences, see Table S3C.
Data Analysis
All values are depicted as mean 6 standard error of the mean
(SEM) and considered significant when P,0.05. Statistical
significance of microarray data was calculated using dChip default
settings, with P,0.05 corrected for multiple comparisons. All
other data were statistically analyzed by 1-way ANOVA with
Newman-Keuls correction.
Supporting Information
Figure S1 Confirmation of Ngn3-activated genes in
human duct cells by conventional (A) and/or quantita-
tive (B) PCR. (A) Some genes are upregulated early after
transduction in AdHA-Ngn3-GFP duct cells (SIM1, PAX4,
NeuroD1), others only 14 days post transduction (PCSK1). The
induction can be transient (SIM1) or sustain for a longer time
period (PAX4). (B) Gene expression levels were compared to
cyclophilin mRNA levels 14 days post transduction. Real-time
PCR data confirms the observed upregulation of known Ngn3
target genes (INSM1, NEUROD1, NKX2.2, PAX4), activation of
the Delta-Notch pathway (DLL1, HES6) and neuro-endocrine
markers (CGA, GCK, SYP) (n$3).
(TIF)
Figure S2 Annotated heat map representation of Ngn3-
regulated genes in suspension cultured human duct
cells. This figure represents an annotated version of Figure 1,
showing the n=140 Ngn3-activated genes on HG133A micro-
array. Further details on fold-regulation and P values can be found
in Tables S1, S2.
(TIF)
Table S1 Full table of Ngn3-activated genes in suspen-
sion cultured human duct cells. 198 non-redundant
transcripts are induced $1.5-fold (LBC, unpaired P,0.05, n=3)
at 3 and/or 14 dpt (140 transcripts on HG133A and 58 on
HG133B array). * P,0.05, n=3; right panel indicates array
subtype (HG133A or B) and probe set ID. For transcripts
represented on HG133A, the gene cluster (cluster A, B, C or
miscellaneous, MISC) in Figure 1 is indicated in last column.
(PDF)
Table S2 Full table of Ngn3-suppressed genes in
suspension cultured human duct cells. 83 transcripts are
suppressed $1.5-fold (LBC, unpaired P,0.05, n=3) at 3 and/or
14 dpt (48 transcripts on HG133A and 35 on HG133B array).
*P,0.05, n=3; right panel indicates array subtype (HG133A or
B) and probe set ID.
(PDF)
Table S3 Oligonucleotides used for RT-PCR (A), RT-qPCR
(B) and amplification of DNA from immunoprecipitated chroma-
tin (C).
(PDF)
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